Case Study

Biosimilar Producer Relies On Flexible Development Platform To Speed Time To Market

Source: Thermo Fisher Scientific
Biosimilar Producer Relies On Flexible Development Platform To Speed Time To Market

To help drive sales, producers of biosimilar medicines seek to gain as much pricing advantage as possible over their products’ reference biological medicines while maintaining as much profit margin as they can. That’s why they are always looking to minimize production costs, especially in raw materials and labor, their largest cost components. While the costs of the former depend on market prices and a buyer’s negotiating skills, the latter can be best reduced through automation and continuous processing.